Moreover, TGF-β, whose activity is increased in systemic sclerosis, favored the expansion of KLRG1− ILC2s while simultaneously decreasing their production of IL-10 in the skin of systemic sclerosis patients and increasing myofibroblast differentiation (206). Here, TGFB1 is linked to systemic sclerosis.